Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway

Miao, HJ; Geng, YJ; Li, Y; Tang, SJ; Feng, FL; Li, WJ; Li, YS; Liu, LG; Zhang, R; Qiu, SM; Wu, Y; Wang, ZY; Wang, ZY; Shao, ZY; Liu, K; Zou, L; Yang, M; Zhao, YH; Chen, C; Li, ZZ; Zhang, DD; Peng, P; Qiang, XY; Wu, F; He, YN; Chen, LN; Xiang, DX; Jiang, XQ; Li, ML; Liu, Y; Liu, YB

Li, ML; Liu, YB (通讯作者),Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Biliary Pancreat Surg, Shanghai 200127, Peoples R China.;Jiang, XQ (通讯作者),Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg, Shanghai 200433, Peoples R China.;Xiang, DX; Liu, Y; Liu, YB (通讯作者),Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200127, Peoples R China.;Li, ML; Liu, YB (通讯作者),Shanghai Key Lab Biliary Tract Dis Res, Shanghai 200127, Peoples R China.

CELLULAR ONCOLOGY, 2022; 45 (4): 689

Abstract

Purpose This study aimed to investigate the efficiency of our chemically synthesized TT-00420, a novel spectrum-selective multiple protein kinase inhi......

Full Text Link